NeuroPace Inc (NPCE): Shareholders' Equity
$19.03M
As of 2025-12-31
$11.88M
As of 2026-06-30
-18.2%
3-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $19.03M | +137.5% | 2026-03-03, Balance as of period end |
| 2024-12-31 | $8.01M | -61.2% | 2026-03-03, Balance as of period end |
| 2023-12-31 | $20.65M | -40.6% | 2025-03-04, Balance as of period end |
| 2022-12-31 | $34.78M | -52.7% | 2024-03-05, Balance as of period end |
| 2021-12-31 | $73.50M | n/m | 2023-03-02, Balance as of period end |
| 2020-12-31 | -$147.83M | n/a | 2022-03-10, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| NeuroPace Inc (NPCE) | 2025-12-31 | $19.03M | +137.5% |
| Beta Bionics, Inc. (BBNX) | 2025-12-31 | $287.61M | n/m |
| Kestra Medical Technologies, Ltd. (KMTS) | 2026-04-30 | $259.66M | +26.4% |
| Pulmonx Corp (LUNG) | 2025-12-31 | $54.12M | -36.9% |
| Anika Therapeutics, Inc. (ANIK) | 2025-12-31 | $143.47M | -6.8% |
| Orasure Technologies Inc (OSUR) | 2025-12-31 | $340.83M | -16.9% |
| Delcath Systems, Inc. (DCTH) | 2025-12-31 | $111.22M | +61.8% |
| Iradimed Corp (IRMD) | 2025-12-31 | $94.62M | +9.0% |
| TELA Bio, Inc. (TELA) | 2025-12-31 | $6.31M | -77.8% |
Compare NPCE, BBNX, KMTS, LUNG side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗